105900-46-7

Basic information

• Product Name: 4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)-
• Synonyms: PseudoerythromycinA hemiketal
• CAS NO: 105900-46-7
• Molecular Formula: C37H67 N O13
• Molecular Weight: 733.938
• Mol File: 105900-46-7.mol
• Article Data: 0

Chemical Properties

• Melting Point: 220 - 225°C
• Boiling Point: 826.1±65.0 °C(Predicted)
• Density: 1.22±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)-(105900-46-7)
• EPA Substance Registry System: 4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)-(105900-46-7)

Safety Data

• Hazardous Substances Data: 105900-46-7(Hazardous Substances Data)

Usage

Description

4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)is a complex organic compound with a unique molecular structure. It is characterized by its bicyclic ring system, multiple hydroxyl and methyl groups, and various glycosidic linkages. 4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)is an impurity of Erythromycin, an antibiotic, and is considered a contaminant of emerging concern.

Uses

Used in Pharmaceutical Industry:
4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)is used as an impurity in the production of Erythromycin, an antibiotic. It is important to monitor and control the levels of this compound in pharmaceutical products to ensure safety and efficacy.
Used in Environmental Monitoring:
As a contaminant of emerging concern, 4,13-Dioxabicyclo[8.2.1]tridecan-5-one,7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1S,2R,3R,6R,7S,8S,9R,10R,12R)is used in environmental monitoring to assess the presence and impact of this compound in the environment. This helps in understanding its potential risks and developing strategies for mitigation.

Downstream Products

• 33396-29-1 erythromycin A enol ether 
• 23893-13-2 erythromycin A 6,9;9,12-spiroketal 
• 105882-69-7 pseudoerythromycin A enol ether 
• 123-38-6 propionaldehyde 
• 105882-71-1 C₃₄H₅₉NO₁₂